Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Cancer
Published in: BMC Cancer 1/2011

Open Access 01-12-2011 | Research article

Differential expression of THOC1 and ALY mRNP biogenesis/export factors in human cancers

Authors: María S Domínguez-Sánchez, Carmen Sáez, Miguel A Japón, Andrés Aguilera, Rosa Luna

Published in: BMC Cancer | Issue 1/2011

Login to get access

Abstract

Background

One key step in gene expression is the biogenesis of mRNA ribonucleoparticle complexes (mRNPs). Formation of the mRNP requires the participation of a number of conserved factors such as the THO complex. THO interacts physically and functionally with the Sub2/UAP56 RNA-dependent ATPase, and the Yra1/REF1/ALY RNA-binding protein linking transcription, mRNA export and genome integrity. Given the link between genome instability and cancer, we have performed a comparative analysis of the expression patterns of THOC1, a THO complex subunit, and ALY in tumor samples.

Methods

The mRNA levels were measured by quantitative real-time PCR and hybridization of a tumor tissue cDNA array; and the protein levels and distribution by immunostaining of a custom tissue array containing a set of paraffin-embedded samples of different tumor and normal tissues followed by statistical analysis.

Results

We show that the expression of two mRNP factors, THOC1 and ALY are altered in several tumor tissues. THOC1 mRNA and protein levels are up-regulated in ovarian and lung tumors and down-regulated in those of testis and skin, whereas ALY is altered in a wide variety of tumors. In contrast to THOC1, ALY protein is highly detected in normal proliferative cells, but poorly in high-grade cancers.

Conclusions

These results suggest a differential connection between tumorogenesis and the expression levels of human THO and ALY. This study opens the possibility of defining mRNP biogenesis factors as putative players in cell proliferation that could contribute to tumor development.
Appendix
Available only for authorised users
Literature
1.
Luna R, Gaillard H, González-Aguilera C, Aguilera A: Biogenesis of mRNPs: integrating different processes in the eukaryotic nucleus. Chromosoma. 2008, 117: 319-331. 10.1007/s00412-008-0158-4.CrossRefPubMed
2.
Sommer P, Nehrbass U: Quality control of messenger ribonucleoprotein particles in the nucleus and at the pore. Curr Opin Cell Biol. 2005, 17: 294-301. 10.1016/j.ceb.2005.04.007.CrossRefPubMed
3.
Danckwardt S, Hentze MW, Kulozik AE: 3' end mRNA processing: molecular mechanisms and implications for health and disease. EMBO J. 2008, 27: 482-498. 10.1038/sj.emboj.7601932.CrossRefPubMedPubMedCentral
4.
Wang GS, Cooper TA: Splicing in disease: disruption of the splicing code and the decoding machinery. Nat Rev Genet. 2007, 8: 749-761. 10.1038/nrg2164.CrossRefPubMed
5.
Aguilera A: Cotranscriptional mRNP assembly: from the DNA to the nuclear pore. Curr Opin Cell Biol. 2005, 17: 242-250. 10.1016/j.ceb.2005.03.001.CrossRefPubMed
6.
Chavez S, Beilharz T, Rondon AG, Erdjument-Bromage H, Tempst P, Svejstrup JQ, Lithgow T, Aguilera A: A protein complex containing Tho2, Hpr1, Mft1 and a novel protein, Thp2, connects transcription elongation with mitotic recombination in Saccharomyces cerevisiae. EMBO J. 2000, 19: 5824-5834. 10.1093/emboj/19.21.5824.CrossRefPubMedPubMedCentral
7.
Rehwinkel J, Herold A, Gari K, Kocher T, Rode M, Ciccarelli FL, Wilm M, Izaurralde E: Genome-wide analysis of mRNAs regulated by the THO complex in Drosophila melanogaster. Nat Struct Mol Biol. 2004, 11: 558-566. 10.1038/nsmb759.CrossRefPubMed
8.
Strasser K, Masuda S, Mason P, Pfannstiel J, Oppizzi M, Rodríguez-Navarro S, Rondón AG, Aguilera A, Struhl K, Reed R, Hurt E: TREX is a conserved complex coupling transcription with messenger RNA export. Nature. 2002, 417: 304-308. 10.1038/nature746.CrossRefPubMed
9.
Rondón AG, Jimeno S, García-Rubio M, Aguilera A: Molecular evidence that the eukaryotic THO/TREX complex is required for efficient transcription elongation. J Biol Chem. 2003, 278: 39037-39043.CrossRefPubMed
10.
García-Rubio M, Chávez S, Huertas P, Tous C, Jimeno S, Luna R, Aguilera A: Different physiological relevance of yeast THO/TREX subunits in gene expression and genome integrity. Mol Genet Genomics. 2008, 279: 123-132.CrossRefPubMed
11.
Jimeno S, Rondón AG, Luna R, Aguilera A: The yeast THO complex and mRNA export factors link RNA metabolism with transcription and genome instability. EMBO J. 2002, 21: 3526-3535. 10.1093/emboj/cdf335.CrossRefPubMedPubMedCentral
12.
Guo S, Hakimi MA, Baillat D, Chen X, Farber MJ, Klein-Szanto AJ, Cooch NS, Godwin AK, Shiekhattar R: Linking transcriptional elongation and messenger RNA export to metastatic breast cancers. Cancer Res. 2005, 65: 3011-3016.PubMed
13.
Wang X, Chang Y, Li Y, Zhang X, Goodrich DW: Thoc1/Hpr1/p84 is essential for early embrionic development in the mouse. Mol Cell Biol. 2006, 26: 4362-7. 10.1128/MCB.02163-05.CrossRefPubMedPubMedCentral
14.
Durfee T, Mancini MA, Jones D, Elledge SJ, Lee WH: The amino-terminal region of the retinoblastoma gene product binds a novel nuclear matrix protein that co-localizes to centers for RNA processing. J Cell Biol. 1994, 127: 609-622. 10.1083/jcb.127.3.609.CrossRefPubMed
15.
Yang J, Li Y, Khoury T, Alrawi S, Goodrich DW, Tan D: Relationships of hHpr1/p84/Thoc1 expression to clinicopathologic characteristics and prognosis in non-small cell lung cancer. Ann Clin Lab Sci. 2008, 38: 105-112.PubMedPubMedCentral
16.
Lukk M, Kapushesky M, Nikkilä J, Parkinson H, Goncalves A, Huber W, Ukkonen E, Brazma A: A global map of human gene expression. Nat Biotechnol. 2010, 28 (4): 322-4. 10.1038/nbt0410-322.CrossRefPubMedPubMedCentral
17.
Berglund L, Björling E, Oksvold P, Fagerberg L, Asplund A, Szigyarto CA, Persson A, Ottosson J, Wernèrus H, Nilsson P, Lundberg E, Sivertsson A, Navani S, Wester K, Kampf C, Hober S, Pontèn F, Uhlèn M: A Genecentric Human Protein Atlas for Expression Profiles Based on Antibodies. Mol Cell Proteomics. 2008, 7 (10): 2019-27. 10.1074/mcp.R800013-MCP200.CrossRefPubMed
18.
Winston F: Control of eukaryotic transcription elongation. Genome Biol. 2001, 2: 1016-10.1186/gb-2001-2-2-reviews1006.CrossRef
19.
Katahira J, Inoue H, Hurt E, Yoneda Y: Adaptor Aly and co-adaptor Thoc5 function in the Tap-p15-mediated nuclear export of HSP70 mRNA. EMBO J. 2009, 28: 556-567. 10.1038/emboj.2009.5.CrossRefPubMedPubMedCentral
20.
Merz C, Urlaub H, Will CL, Lührmann R: "Protein composition of human mRNPs spliced in vitro and differential requirements for mRNP protein recruitment". RNA. 2007, 13: 116-128. 10.1261/rna.336807.CrossRefPubMedPubMedCentral
21.
Li Y, Lin AW, Zhang X, Wang Y, Wang X, Goodrich DW: Cancer cells and normal cells differ in their requirements for Thoc1. Cancer Res. 2007, 67: 6657-6664. 10.1158/0008-5472.CAN-06-3234.CrossRefPubMedPubMedCentral
22.
Huertas P, Aguilera A: Cotranscriptionally formed DNA:RNA hybrids mediate transcription elongation impairment and transcription-associated recombination. Mol Cell. 2003, 12: 711-721. 10.1016/j.molcel.2003.08.010.CrossRefPubMed
23.
Wang X, Chinnam M, Wang J, Zhang X, Marcon E, Moens P, Goodrich DW: Thoc1 deficiency compromises gene expression necessary for normal testis development in the mouse. Mol Cell Biol. 2009, 29: 2794-803. 10.1128/MCB.01633-08.CrossRefPubMedPubMedCentral
24.
Mancini A, Niemann-Seyde SC, Pankow R, El Bounkari O, Klebba-Färber S, Koch A, Jaworska E, Spooncer E, Gruber AD, Whetton AD, Tamura T: THOC5/FMIP, an mRNA export TREX complex protein, is essential for hematopoietic primitive cell survival in vivo. BMC Biol. 2010, 8: 1-10.1186/1741-7007-8-1.CrossRefPubMedPubMedCentral
25.
Okada M, Jang SW, Ye K: Akt phosphorylation and nuclear phosphoinositide association mediate mRNA export and cell proliferation activities by ALY. Proc Natl Acad Sci USA. 2008, 105: 8649-8654. 10.1073/pnas.0802533105.CrossRefPubMedPubMedCentral
26.
Mertz JA, Kobayashi R, Dudley JP: ALY is a common coactivator of RUNX1 and c-Myb on the type B leukemogenic virus enhancer. J Virol. 2007, 81: 3503-3513. 10.1128/JVI.02253-06.CrossRefPubMedPubMedCentral
27.
Swaminathan S, Kile AC, MacDonald EM, Koepp DM: Yra1 is required for S phase entry and affects Dia2 binding to replication origins. Mol Cell Biol. 2007, 27: 4674-4684. 10.1128/MCB.02052-06.CrossRefPubMedPubMedCentral
28.
Gwizdek C, Hobeika M, Klus B, Ossareh-Nazari B, Dargemont C, Rodriguez MS: The mRNA nuclear export factor Hpr1 is regulated by Rsp5 mediated ubiquitylation. J Biol Chem. 2005, 280 (14): 13401-5. 10.1074/jbc.C500040200.CrossRefPubMed
29.
Smolka MB, Albuquerque CP, Chen S, Zhou H: Proteome-wide identification of in vivo targets of DNA damage checkpoint kinases. Proc Natl Acad Sci USA. 2007, 104 (25): 10364-9. 10.1073/pnas.0701622104.CrossRefPubMedPubMedCentral
30.
Masuda S, Das R, Cheng H, Hurt E, Dorman N, Reed R: Recruitment of the human TREX complex to mRNA during splicing. Genes Dev. 2005, 19: 1512-1517. 10.1101/gad.1302205.CrossRefPubMedPubMedCentral
31.
Zenklusen D, Vinciguerra P, Wyss JC, Stutz F: Stable mRNP formation and export require cotranscriptional recruitment of the mRNA export factors Yra1p and Sub2p by Hpr1p. Mol Cell Biol. 2002, 22: 8241-8253. 10.1128/MCB.22.23.8241-8253.2002.CrossRefPubMedPubMedCentral
32.
Cheng H, Dufu K, Lee CS, Hsu JL, Dias A, Reed R: Human mRNA export machinery recruited to the 5' end of mRNA. Cell. 2006, 127: 1389-1400. 10.1016/j.cell.2006.10.044.CrossRefPubMed
33.
Yoh SM, Cho H, Pickle L, Evans RM, Jones KA: The Spt6 SH2 domain binds Ser2-P RNAPII to direct Iws1-dependent mRNA splicing and export. Genes Dev. 2007, 21: 160-174. 10.1101/gad.1503107.CrossRefPubMedPubMedCentral
Metadata
Title
Differential expression of THOC1 and ALY mRNP biogenesis/export factors in human cancers
Authors
María S Domínguez-Sánchez
Carmen Sáez
Miguel A Japón
Andrés Aguilera
Rosa Luna
Publication date
01-12-2011
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2011
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/1471-2407-11-77

Other articles of this Issue 1/2011

BMC Cancer 1/2011 Go to the issue

Research article

Gene expression profile of circulating tumor cells in breast cancer by RT-qPCR

Research article

Admission of advanced lung cancer patients to intensive care unit: A retrospective study of 76 patients

Research article

An in vitro co-culture model of esophageal cells identifies ascorbic acid as a modulator of cell competition

Research article

Significant survival improvement of patients with recurrent breast cancer in the periods 2001-2008 vs. 1992-2000

Research article

Metabolic markers in relation to hypoxia; staining patterns and colocalization of pimonidazole, HIF-1α, CAIX, LDH-5, GLUT-1, MCT1 and MCT4

Research article

Long term outcome of high-risk neuroblastoma patients after immunotherapy with antibody ch14.18 or oral metronomic chemotherapy
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits